Literature DB >> 33867716

Pseudohyperkalemia in Serum and Plasma: The Phenomena and Its Clinical Implications.

Mala Mahto1, Mukunda Kumar1, Sushil Kumar1, Ayan Banerjee1.   

Abstract

Hyperkalemia is a life threatening electrolyte derangement that must be recognized and treated quickly. Pseudohyperkalemia is defined as a difference between serum and plasma potassium concentration of more than 0.4 meq/L with serum values on the higher side when both the samples are obtained at the same time, remain at room temperature and are tested within 1 h of sample collection. Given the implication of basing medical decisions on falsely elevated potassium levels, timely identification of the entity of pseudohyperkalemia and differentiating it from true hyperkalemia becomes utmost important. Here we present a case report of a 36 year old female admitted with a provisional diagnosis of pyrexia of unknown origin with hepatosplenomegaly and anaemia under evaluation. During hospital stay her potassium levels in whole blood, serum and plasma reportedly differed significantly. An abnormal WBC count beyond assay range was reported and during subsequent investigations this lead to a peripheral smear being advised and diagnosis revealed chronic lymphoblastic leukaemia with blast crisis and 86% blast cells. In patients with leukocytosis and thrombocytosis, pseudohyperkalemia may exist in the absence of electrocardiogram changes or other clinical manifestations of true hyperkalemia thus leading to reevaluation of potassium values in serum, plasma and whole blood to arrive at the true picture. © Association of Clinical Biochemists of India 2020.

Entities:  

Keywords:  CLL; Leukocytosis thrombocytosis; Pseudohyperkalemia; Reverse pseudohyperkalemia

Year:  2020        PMID: 33867716      PMCID: PMC7994497          DOI: 10.1007/s12291-020-00889-3

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  18 in total

1.  V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.

Authors:  Alexander Kröber; Till Seiler; Axel Benner; Lars Bullinger; Elsbeth Brückle; Peter Lichter; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

2.  Platelet function in thrombocythemia. The effect of platelets and serotonin on serum potassium and bilirubin.

Authors:  I M NILSSON; B SKANSE; S E BJORKMAN; F SERIN
Journal:  Acta Med Scand       Date:  1960-08-10

3.  Reverse pseudohyperkalemia in heparin plasma samples from a child with T cell acute lymphoblastic leukemia with hyperleukocytosis.

Authors:  Daniel Garwicz; Mattias Karlman; Ingrid Øra
Journal:  Clin Chim Acta       Date:  2010-11-03       Impact factor: 3.786

4.  Pseudohyperkalemia and platelet counts.

Authors:  M W Nijsten; B J de Smet; A S Dofferhoff
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

5.  Pseudohyperkalemia in extreme leukocytosis.

Authors:  G Colussi; D Cipriani
Journal:  Am J Nephrol       Date:  1995       Impact factor: 3.754

Review 6.  Pseudohyperkalemia in serum: a new insight into an old phenomenon.

Authors:  Nikolaos Sevastos; George Theodossiades; Athanasios J Archimandritis
Journal:  Clin Med Res       Date:  2008-05

Review 7.  Novel functions of vimentin in cell adhesion, migration, and signaling.

Authors:  Johanna Ivaska; Hanna-Mari Pallari; Jonna Nevo; John E Eriksson
Journal:  Exp Cell Res       Date:  2007-04-14       Impact factor: 3.905

8.  CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.

Authors:  Silvia Deaglio; Tiziana Vaisitti; Semra Aydin; Luciana Bergui; Giovanni D'Arena; Lisa Bonello; Paola Omedé; Maria Scatolini; Ozren Jaksic; Giovanna Chiorino; Dimitar Efremov; Fabio Malavasi
Journal:  Blood       Date:  2007-08-15       Impact factor: 22.113

9.  Incorrect order of draw could be mitigate the patient safety: a phlebotomy management case report.

Authors:  Gabriel Lima-Oliveira; Giuseppe Lippi; Gian Luca Salvagno; Martina Montagnana; Geraldo Picheth; Gian Cesare Guidi
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

10.  Reverse Pseudohyperkalemia: An Important Clinical Entity in Chronic Lymphocytic Leukemia.

Authors:  Sahar Mansoor; Noa G Holtzman; Ashkan Emadi
Journal:  Case Rep Hematol       Date:  2015-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.